Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Saisei Ventures is a venture capital firm founded by biotechnology veterans and investors, established to enhance the Japanese biotech ecosystem. The firm connects Japanese research with global expertise to improve patient outcomes through innovative solutions. Founded in Japan, Saisei Ventures operates offices in both Cambridge, USA, and Tokyo, Japan, reflecting its bi-regional investment strategy.
The firm specializes in the life sciences sector, particularly in advanced therapeutic platforms. Saisei Ventures is committed to addressing serious diseases by leveraging the Japanese ecosystem while sourcing technologies globally. The name 'Saisei' embodies the concepts of regrowth and regeneration, aligning with their mission to drive transformative biotech advancements.
Saisei Ventures has positioned itself as a leading venture capital firm for the Japanese biotech ecosystem, focusing on creating and investing in companies that can compete on a global scale. The firm emphasizes a hands-on approach, actively participating in company creation and development.
Saisei Ventures specializes in the life sciences sector, with a particular emphasis on advanced therapeutic platforms. Their investment strategy includes modalities such as cell immunotherapies, pluripotent cell replacement therapies, and gene therapy approaches. The firm supports programs that demonstrate a clear path to clinical and commercial scale manufacturing, addressing serious diseases with innovative solutions.
Geographically, Saisei Ventures focuses primarily on Japan, while also considering opportunities in the United States and Canada. The firm invests in seed through early clinical stage companies, particularly those that are proof of concept to Investigational New Drug (IND) stage. Saisei Ventures seeks to combine Western expertise with Japanese innovation, aiming to build globally competitive companies that improve patient health outcomes.
Saisei Ventures partners with a select group of innovative companies in the biotech sector. Their portfolio includes:
This diverse portfolio reflects Saisei Ventures' commitment to advancing healthcare through innovative biotech solutions.
Dr. Sven Kili: Partner at Saisei Ventures, Dr. Kili has a background in biotechnology and has led numerous successful investments in the life sciences sector. His expertise includes advanced therapeutic platforms and company creation.
To pitch to Saisei Ventures, founders should use the email address ideas@saiseiventures.com. It is important to include a comprehensive deck that outlines the business model, market opportunity, and team qualifications. The firm prefers detailed information that demonstrates a clear path to clinical and commercial scale manufacturing.
Response times may vary, but founders should expect to hear back within a few weeks. Warm introductions are beneficial but not strictly necessary.
Saisei Ventures runs the Bridge-to-Biotech initiative, aimed at helping Japanese scientists translate their discoveries into venture-ready biotech companies. Additionally, they announced the Executive Fellows Program in April 2025, designed to enhance Japan's biotech leadership pipeline.
In April 2025, Saisei Ventures announced the launch of its Executive Fellows Program, aimed at enhancing Japan's biotech leadership pipeline. This initiative reflects the firm's commitment to fostering talent within the Japanese biotech ecosystem.
Additionally, Saisei Ventures continues to expand its portfolio, focusing on innovative companies that align with its investment thesis in advanced therapeutic platforms.
What are Saisei Ventures' investment criteria?
Saisei Ventures invests in the life sciences sector, focusing on advanced therapeutic platforms such as cell immunotherapies and gene therapies. They seek companies with a clear path to clinical and commercial scale manufacturing.
How can I apply or pitch to Saisei Ventures?
Founders can pitch their ideas by sending an email to ideas@saiseiventures.com. It is advisable to include a detailed overview of the business model, market opportunity, and team background in the pitch.
What makes Saisei Ventures different from other VC firms?
Saisei Ventures combines Japanese scientific innovation with Western biotech expertise, focusing on company creation rather than just passive investment. This hands-on approach allows them to actively participate in the development of their portfolio companies.
What is the geographic scope of Saisei Ventures?
The firm primarily focuses on Japan but also considers investments in the United States and Canada, particularly for companies that can leverage their bi-regional expertise.
What is the typical fund size or check size for investments?
While specific fund sizes are not publicly disclosed, Saisei Ventures typically invests in seed to early clinical stage companies, indicating a focus on early-stage funding.
What kind of post-investment involvement does Saisei Ventures have?
Saisei Ventures takes an active role in the development of its portfolio companies, providing operational support, mentorship, and access to their extensive network in both Japan and the United States.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.